EUVIMEDEUVIMED entdecken
Crossref

Distinct expression and prognostic value of CA19-9 between right- and left-sided colorectal cancer

Yohei Ando, Tatsuya Manabe, Chieko Hotta, Shin Takesue, Hirokazu Noshiro

Surgery Today · 18.09.2026

DOI: 10.1007/s00595-026-03448-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, online erschienen am 18.09.2026. Verfasst von Yohei Ando und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. yando@cc.saga-u.ac.jp. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Right- and left-sided colorectal cancers (CRCs) exhibit distinct clinicopathological and molecular characteristics; however, the differences in tumor marker expression between the two sides remain unclear. We investigated whether tumor marker levels and their clinical relevance vary by tumor-sidedness, which has distinct embryological origins. METHODS: We analyzed 800 patients with colorectal adenocarcinoma (293 right-sided and 507 left-sided) who underwent surgery at Saga University Hospital between January 2012 and December 2024. Serum carcinoembryonic antigen and carbohydrate antigen 19 - 9 (CA19-9) levels were compared between the groups, and their associations with early recurrence were evaluated. RESULTS: Right-sided CRCs was more frequent in older patients, women, and those with mucinous histology. After adjusting for baseline characteristics, serum log CA19-9 levels remained significantly higher in right-sided CRC (1.22 ± 0.59 vs. 1.14 ± 0.45, P = 0.034). Among the 617 patients who underwent curative resection, 53 (8.6%) experienced early recurrence. A multivariable analysis identified log CA19-9 and the pathological stage as independent predictors of early recurrence, with the association for CA19-9 remaining significant only in right-sided disease (odds ratio, 3.710; 95% confidence interval, 1.509-9.726; P = 0.004). CONCLUSION: The serum CA19-9 levels were higher in right-sided CRC after adjusting for baseline characteristics and predicted early recurrence only in right-sided disease.

Schlagwörter

Stichwörter der Autor:innen

CA19-9CEAColorectal cancerLocationTumor marker

Autor:innen und Institutionen

  • Department of Surgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. yando@cc.saga-u.ac.jp.
  • Department of Surgery, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Zitieren

APA

Ando, Y., Manabe, T., Hotta, C., Takesue, S., & Noshiro, H. (2026). Distinct expression and prognostic value of CA19-9 between right- and left-sided colorectal cancer. Surgery Today. https://doi.org/10.1007/s00595-026-03448-0

Vancouver

Ando Y, Manabe T, Hotta C, Takesue S, Noshiro H. Distinct expression and prognostic value of CA19-9 between right- and left-sided colorectal cancer. Surgery Today. 2026. doi:10.1007/s00595-026-03448-0

BibTeX
@article{Ando2026,
  author = {Ando, Yohei and Manabe, Tatsuya and Hotta, Chieko and Takesue, Shin and Noshiro, Hirokazu},
  title = {Distinct expression and prognostic value of CA19-9 between right- and left-sided colorectal cancer},
  journal = {Surgery Today},
  year = {2026},
  doi = {10.1007/s00595-026-03448-0}
}
Kostenlos starten →